PMS-LIDOCAINE VISCOUS 2% LIQUID

Država: Kanada

Jezik: angleščina

Source: Health Canada

Kupite ga zdaj

Lastnosti izdelka Lastnosti izdelka (SPC)
07-04-2016

Aktivna sestavina:

LIDOCAINE HYDROCHLORIDE

Dostopno od:

PHARMASCIENCE INC

Koda artikla:

N01BB02

INN (mednarodno ime):

LIDOCAINE

Odmerek:

2%

Farmacevtska oblika:

LIQUID

Sestava:

LIDOCAINE HYDROCHLORIDE 2%

Pot uporabe:

DENTAL

Enote v paketu:

100,50 ML

Tip zastaranja:

OTC

Terapevtsko območje:

LOCAL ANESTHETICS

Povzetek izdelek:

Active ingredient group (AIG) number: 0101280001; AHFS:

Status dovoljenje:

MARKETED

Datum dovoljenje:

1990-12-31

Lastnosti izdelka

                                PRESCRIBING INFORMATION
PMS-LIDOCAINE VISCOUS 2%
Lidocaine Hydrochloride Oral Topical Solution, USP
20 mg/mL
Oral Topical Anesthetic
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montreal, Quebec
H4P 2T4
www.pharmascience.com
Date of Revision:
April 6, 2016
Submission Control No: 193450
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 2 of 21 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................8
DRUG INTERACTIONS
....................................................................................................9
DOSAGE AND ADMINISTRATION
..............................................................................11
OVERDOSAGE
................................................................................................................13
ACTION AND CLINICAL PHARMACOLOGY
............................................................14
STORAGE AND STABILITY
..........................................................................................16
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................16
REFERENCES
..................................................................................................................17
PART III: CONSUMER
INFORMATION...............................................................................18
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 3 of 21 _
_ _
PMS-LIDOCAINE VISCOUS 
                                
                                Preberite celoten dokument
                                
                            

Dokumenti v drugih jezikih

Lastnosti izdelka Lastnosti izdelka francoščina 15-04-2016

Opozorila o iskanju, povezana s tem izdelkom